MyMonitor Corporation

MyMonitor Corporation is a healthcare technology company that has developed an AI-driven platform designed to modernize dermatological assessment and clinical research. The system functions by converting standard skin images into structured, objective clinical data, aiming to reduce diagnostic variability and improve the precision of skin condition management. A core feature of the platform is its use of melanin-aware imaging technology, which is intended to support more equitable and inclusive diagnostics across diverse skin tones. Beyond image analysis, the platform provides tools that integrate with healthcare systems and electronic health records to streamline workflows for clinicians and stakeholders in the dermatological field.

This technology is intended to assist a wide range of organizations, including hospitals, clinics, and health systems, by enhancing diagnostic accuracy and facilitating more efficient patient care. Additionally, the platform addresses needs within clinical trials by offering smart recruitment strategies and ensuring diverse patient enrollment. By shifting dermatology toward a more data-driven approach, MyMonitor seeks to transform subjective visual assessments into measurable medical insights, ultimately aiming to improve patient outcomes and support research evidence generation from bedside to benchside. The company, which is based in the United States, focuses on closing the gap between traditional dermatological practice and modern data science.